Deoxynivalenol induced oxidative stress and genotoxicity in human peripheral blood lymphocytes

Wei Yang1, Miao Yu1, Juan Fu1

  • 1Department of Nutrition and Food Hygiene, Hubei Key Laboratory of Food Nutrition and Safety, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, China; Ministry of Education Key Lab of Environment and Health, School of Public Health, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan 430030, China.

Insights

Deoxynivalenol (DON) causes cytotoxicity and genotoxicity in human lymphocytes by inducing oxidative damage. This mycotoxin impairs DNA repair mechanisms, highlighting potential health risks from DON exposure.

Area of Science:

  • Toxicology
  • Cell Biology
  • Molecular Biology

Background:

  • Deoxynivalenol (DON) is a prevalent mycotoxin found in food and feed.
  • Mycotoxins pose significant risks to human and animal health.
  • Understanding DON's cellular and molecular effects is crucial for risk assessment.

Purpose of the Study:

  • To evaluate the cytotoxicity, genotoxicity, and oxidative damage induced by DON in human peripheral blood lymphocytes.
  • To investigate the underlying mechanisms of DON-induced cellular damage.
  • To assess the impact of DON on DNA repair pathways.

Main Methods:

  • Human lymphocytes were exposed to varying concentrations of DON (0-500 ng/mL) for 6, 12, and 24 hours.
  • Cell viability, membrane integrity, and DNA damage were assessed using cellular assays.
  • Oxidative stress markers (lipid peroxidation, 8-OHdG, ROS) were measured.
  • Gene and protein expression of DNA repair enzymes and HO-1 were analyzed via RT-PCR and Western Blot.

Main Results:

  • DON significantly decreased cell viability and caused damage to cell membranes, chromosomes, and DNA.
  • Exposure to DON induced lipid peroxidation and elevated levels of 8-OHdG and reactive oxygen species (ROS).
  • DON enhanced mRNA/protein expression of DNA repair genes and HO-1 at 6 hours but inhibited them at 24 hours.

Conclusions:

  • DON exhibits significant cytotoxicity and genotoxicity in human lymphocytes.
  • The mechanism involves oxidative DNA damage and impaired antioxidase activity.
  • DON interferes with DNA repair pathways, potentially leading to long-term genetic instability.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.0K
Toxicity Testing in Animals01:23

Toxicity Testing in Animals

Toxicity tests in animals are grounded on two main assumptions: first, the effects observed in laboratory animals can be extrapolated to humans, especially when adjusted for body surface area; second, high-dose exposure in animals is essential to identify potential human hazards from lower doses. This is based on the quantal dose-response concept, which faces the challenge of extrapolating results from relatively few test animals to much larger human populations. For example, a 0.01% incidence...
204
Drug Toxicity: Allergic Reactions01:30

Drug Toxicity: Allergic Reactions

Drug-related allergies are immune-mediated responses triggered by the administration of pharmacological agents. These hypersensitivity reactions are classified based on the immune mechanisms involved. The four primary types—Type I, II, III, and IV—are mediated by different immunological pathways and exhibit distinct clinical manifestations.Type I Hypersensitivity/ IgE-Mediated Reactions: Immunoglobulin E (IgE) immediately mediates Type I hypersensitivity reactions. Upon initial...
209
In vitro Mutagenesis01:16

In vitro Mutagenesis

4.9K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
229
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
151